Melissa Levin, MSW, LICSW, spoke with Healio about the unique challenges faced by cancer patients with intellectual or developmental disabilities, and discussed Dana-Farber’s new neuro-inclusive oncology care and empowerment program.

➡️ ms.spr.ly/6019YGTu7

We appreciate New England Patriots La’Michael Pettway (pictured), Nathan Rourke, KJ Osborn, JB & Sione Takitaki for celebrating the 40th anniversary of Kraft Family Blood Donor Center and its generous blood/platelet donors during the Breakfast of Champions held recently Gillette Stadium. #BeAHero

This quick take by @nejm summarizes key findings of just-published research led by Toni Choueiri, MD that shows pembrolizumab after surgery significantly prolongs overall survival in high risk clear-cell renal cell carcinoma. #kidneycancer
CC: Dana-Farber Lank Center for Genitourinary Oncology
nejm.org/do/10.1056/NEJ…

Congrats Kevin Haigis, PhD, Dana-Farber's Chief Scientific Officer - recognized as a Fellow of the American Association for the Advancement of Science (@aaas) for distinguished contributions within biological sciences. Kevin Haigis Lab

Press release: ms.spr.ly/6019Y6Whf

Immunotherapy research in NEJM - For the 1st time in 50 years, results from a phase 3 randomized, placebo-controlled trial show overall survival benefit from adjuvant therapy in patients with kidney cancer. Research by Dana-Farber's Toni Choueiri, MD.

➡️ms.spr.ly/6019Y6WoJ

Congratulations to Dana-Farber's Stuart H. Orkin, MD, who was named one of TIME 100 Most Influential People of 2024. Orkin's research has led to the first gene therapy using #CRISPR to treat sickle cell disease.
Read more ▶️ ms.spr.ly/6011YBwpc

Dana-Farber President and CEO Laurie Glimcher, MD, (Laurie Glimcher MD), and Christopher Lathan, MD, MS, MPH, Chief Clinical Access and Equity Officer, discuss how community hospitals are vital to cancer care in this Boston Herald op-ed.
Read more ➡️ ms.spr.ly/6014YBZj4

'People don't want to talk about this. It's scary.' Dana-Farber's James Tulsky, MD, (@jatulsky) on Boston 25 News discussing the importance of having difficult conversations early on about your health wishes. Today is #NationalHealthCareDecisionsDay

ms.spr.ly/6015YBBTV

“We incorporated their needs and voices into the clinical services offered by our center,” says Kimmie Ng, MD, MPH, (Kimmie Ng, MD, MPH) in this feature in Gastroenterology & Endoscopy News highlighting the work of Dana-Farber's Young-Onset Colorectal Cancer Center. #ColorectalCancer

ms.spr.ly/6011Y6oyL

Life can change in an instant. That's why advance care planning is so important. Today is #NationalHealthcareDecisionsDay . Our palliative care team at Dana-Farber helps patients take control of their own health and teaches them how to start those tough conversations.

Congratulations to Catherine Wu, MD, Dana-Farber who was presented with the Sjöberg Prize by Sweden’s King Carl XVI Gustaf at the Royal Swedish Academy of Sciences Annual Meeting for her pioneering research in personalizing vaccines to treat cancer.

➡️ ms.spr.ly/6015choa3

“Here's what you should know about rising colorectal cancer rates' - Dana-Farber's Kimmie Ng, MD, (@KimmieNgMD) featured in The B-Side discussing the alarming rise of #ColorectalCancer in younger adults.

Read more: ms.spr.ly/6010c7VAp

CC: Dana-Farber's Young-Onset Colorectal Cancer Center

Dana-Farber extends full support to Dr. Francis Collins, former director of the National Institutes of Health, as he publicly announces his prostate cancer diagnosis. Statement below from Toni Choueiri, MD, (Toni Choueiri, MD), Director of Dana-Farber Lank Center for Genitourinary Oncology
CC: @DanaFarber

Toni Choueiri, MD at The Third Transatlantic Exchange in Oncology: liquid biopsy as an emerging approach in precision cancer medicine 🤝

Gustave Roussy / Dana-Farber

April 16th is National Healthcare Decisions Day. A day meant to inspire, educate and empower the public and healthcare providers about the importance of advance care planning. You can learn more about services offered at Dana-Farber here: ms.spr.ly/6015c7upB

Great feature highlighting Dana-Farber Lank Center for Genitourinary Oncology's Stephanie Berg, DO, (@bergsa83) about what drives her passion for treating patients with prostate cancer.

Read more from Movember USA: ms.spr.ly/6017cfS3c

We’re getting ready to wrap up #AACR24 , but not before another full day of poster presentations. Tao Zhang, PhD, Dana-Farber will present findings that obesity promotes #breastcancer progression via complement 1q binding protein.

A study at #AACR24 suggests a program of moderate-to-vigorous aerobic and resistance exercise can improve a key aspect of heart function in survivors of breast, prostate, and colorectal cancer. Dana-Farber's Cami Christopher, MPH, (@ResearchCami) explains more in this video.

Christopher Fletcher, MD, Dana-Farber has received the #AACR24 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research for discoveries transforming the cancer pathology field and establishing innovative therapies.

ms.spr.ly/6017c4cES

Congratulations to Timothy Rebbeck, PhD, (Tim Rebbeck) Dana-Farber for receiving the #AACR24 American Cancer Society Award for Research Excellence in Cancer Epidemiology & Prevention recognizing groundbreaking contributions to cancer prevention standards.

ms.spr.ly/6016c4izg